Hearing Loss, Hearing Products, Patient Care, Practice Building

Popular

Study Shows Hair Cell Regrowth with New Drug

A new approach, published in “Cell Reports,” to regenerate inner ear sensory hair cells is said to lay the groundwork for treating chronic noise-induced hearing loss by the company, Frequency Therapeutics, and its co-founders who are drawing on research from Brigham and Women's Hospital (BWH), Harvard Medical School, Mass Eye and Ear Infirmary, and MIT. The program is expected to progress to into human clinical trials within the next 18 months.

Hearing Aids

Latest

Nuheara IQbuds2 Max Selected for ‘TIME’s 2020 Best Inventions’

According to Nuheara, what makes IQbuds² MAX unique is the EarID clinically certified personalization system embedded in the IQbuds App. EarID helps allow consumers “to self-assess, self-fit, and auto calibrate their IQbuds² MAX to their own personal hearing profile using National Acoustic Labs NAL-NL2 hearing aid prescription algorithms.”